Aptadel Therapeutics
PrivateLast Round
VC Round
Mar 24, 2026
Total Funding Raised
$2.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aptadel Therapeutics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in March 2026.
Aptadel Therapeutics is a drug discovery company developing an RNA-based platform of targeted therapy to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptadel Therapeutics Comparables
Compare Aptadel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RNA Nanotherapeutics | 72% | |
| Oligon Therapeutics | 67% | |
| TME Pharma N.V. | 67% |
For institutional investors. Book with your work email.
Aptadel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2026 | ||||
| Grant | Feb 11, 2025 | ||||
| Seed | Jan 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aptadel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newsight Tech Angels | VC Round |
| Little Warrior Foundation | VC Round, Grant |
| Fundación Alba Pérez | Seed |
| Chasing Science | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 43% MoM.
- Apr 22, 2026
Monthly visitors increased 180% MoM, reaching 829.
For institutional investors. Book with your work email.
Aptadel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aptadel Therapeutics's valuation, stock price, and market status.
Is Aptadel Therapeutics a public or private company?
Aptadel Therapeutics is a private company.
What is the current stock price of Aptadel Therapeutics?
Aptadel Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aptadel Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aptadel Therapeutics worth (valuation)?
Valuation information for Aptadel Therapeutics is not publicly available.
Can I buy Aptadel Therapeutics stock?
Aptadel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aptadel Therapeutics's last funding round?
Aptadel Therapeutics's most recent funding round was VC Round on March 24, 2026.
Who are the main investors in Aptadel Therapeutics?
Key investors in Aptadel Therapeutics include Newsight Tech Angels.
Will Aptadel Therapeutics IPO soon?
No public IPO plans have been announced for Aptadel Therapeutics.
How can I track Aptadel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aptadel Therapeutics's shares on secondary markets.